Quantcast
Home / Practice Areas / Business and Civil Practice / Glaxo, U.S. reach tentative $3B deal over Avandia

Glaxo, U.S. reach tentative $3B deal over Avandia

GlaxoSmithKline has announced a tentative deal with the federal government under which the drug company would pay a record $3 billion to end an investigation into the marketing of Avandia for “off-label” uses.